FDA Warning Letter — Hillcrest BP

Case 559374 — FEI 3014560836

The FDA took a Warning Letter action against Hillcrest BP on Jul 12, 2018 (Wooster, OH). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Hillcrest BP
Date
Jul 12, 2018
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
Wooster, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.